LoboStim is a company focused on patient first innovation in the neuromodulation space. Every year, approximately 400,000 chronic pain patients are indicated for Spinal Cord Stimulation (SCS). The SCS treatment is meant to relieve pain through electrical stimulation of the spinal nerves, but the process currently invokes more pain with its invasive trial procedure.LoboStim aims to revolutionize the SCS market with the creation of a non-invasive, stimulating diagnostic tool that can be applied to the outside of the back with the same outcomes as the traditional, implantable trial leads.